Sabine Blum

Featured in: Favicon

nature.com Favicon

bloodjournal.org Favicon

onlinelibrary.wiley.com

Articles

Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine - Blood Cancer Journal

Jun 19, 2023 | nature.com | Jacobien R. Hilberink |Thomas Pabst |Saskia K. Klein |Georg Stussi |Markus G. Manz |Sabine Blum | +2 more

AbstractTreatment choice according to the individual conditions remains challenging, particularly in older patients with acute myeloid leukemia (AML) and high risk myelodysplastic syndrome (MDS). The impact of performance status, comorbidities, and physical functioning on survival is not well defined for patients treated with hypomethylating agents.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →